Table 2.
Mean comorbidities, no. medications, and scores for depression, anxiety, and quality of life by dryness sensitivity classification. Proportions of patients in the different groups with specific comorbidities and receiving particular treatmentsa
Ocular sensitivity | Oral sensitivity | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Stoical (n = 351) | Accurate (n = 130) | Sensitive (n = 200) | Comparison | P | Stoical (n = 444) | Accurate (n = 179) | Sensitive (n = 58) | Comparison | P | |
No. comorbidities | 3.4 ± 2.3 | 3.9 ± 2.5 | 3.8 ± 2.6 | F2,678 = 2.90 | 0.056 | 3.4 ± 2.3 | 3.8 ± 2.6 | 3.9 ± 2.7 | F2,678 = 9.5 | 0.078 |
No. medications | 5.5 ± 4.1 | 5.7 ± 3.7 | 6.3 ± 4.2 | F2,678 = 2.52 | 0.081 | 5.4 ± 3.9b | 6.6 ± 4.5c | 5.8 ± 3.9d | F2,678 = 4.97e | 0.007e |
Anxiety (HADS) | 7.3 ± 4.5b | 8.4 ± 4.8c | 8.9 ± 4.4c | F2,661 = 8.75e | < 0.001e | 7.3 ± 4.4b | 9.0 ± 4.8c | 10.2 ± 4.0c | F2,661 = 16.45e | < 0.001e |
Depression (HADS) | 5.3 ± 3.7b | 6.4 ± 4.3c | 6.9 ± 4.3c | F2,661 = 11.23e | < 0.001e | 5.2 ± 3.6b | 7.2 ± 4.4c | 8.1 ± 4.3c | F2,661 = 24.00e | < 0.001e |
Quality of life (VAS) | 63.8 ± 20.6b | 56.6 ± 22.5c | 56.3 ± 21.2c | F2,659 = 10.09e | < 0.001e | 63.4 ± 20.2b | 54.3 ± 22.5c | 53.9 ± 22.7c | F2,659 = 14.14e | < 0.001e |
Specific comorbidities | ||||||||||
Fibromyalgia | 6.3c | 8.5d | 14.0b | Χ2(2) = 9.39e | 0.009e | 7.0c | 11.2d | 17.2b | Χ2(2) = 8.08e | 0.018e |
IBS | 5.4c | 7.7d | 12.0b | Χ2(2) = 7.70e | 0.021e | 7.7c | 5.0c | 17.2b | Χ2(2) = 9.13e | 0.010e |
Mental illness | 3.1 | 6.2 | 4.0 | Χ2(2) = 2.27 | 0.321 | 2.7 | 6.7 | 5.2 | Χ2(2) = 5.61 | 0.061 |
Treatments, % | ||||||||||
Xerogenic medication use | 37.3b | 46.2d | 50.0c | Χ2(2) = 9.14e | 0.010e | 39.2 | 48.6 | 51.7 | Χ2(2) = 6.72e | 0.035e |
Symptomatic treatment for dryness | 97.7 | 96.9 | 97.5 | Χ2(2) = 0.25 | 0.883 | 97.1 | 97.8 | 100.0 | Χ2(2) = 1.875 | 0.392 |
Pilocarpine | 7.1 | 9.2 | 7.5 | Χ2(2) = 0.61 | 0.739 | 7.2 | 10.1 | 3.4 | Χ2(2) = 3.04 | 0.218 |
Saliva substitute | – | – | – | – | 40.1b | 56.4c | 43.1d | Χ2(2) = 13.83e | 0.001e | |
Lachrymal substitute | 82.6c | 83.1c | 71.5b | Χ2(2) = 10.95e | 0.004e | – | – | – | – | |
Punctal plugging or cauterization | 18.8b | 33.8c | 22.0d | Χ2(2) = 12.33e | 0.002e | – | – | – | – |
Values are the mean ± SD unless otherwise indicated. HADS = Hospital Anxiety and Depression Scale; VAS = visual analog scale; IBS = irritable bowel syndrome.
Significantly different from groups ‡ and § in post hoc tests (P < 0.05 for continuous measures, P < 0.017 for categorical measures).
Significantly different from groups † and § in post hoc tests (P < 0.05 for continuous measures, P < 0.017 for categorical measures).
Significantly different from groups † and ‡ in post hoc tests (P < 0.05 for continuous measures, P < 0.017 for categorical measures).
Statistically significant.